Cystic fibrosis: organoid technology to identify new antimicrobial therapeutic strategies
Cystic fibrosis is the most common rare genetic disease. In these patients, respiratory infections contribute[…]
Cystic fibrosis is the most common rare genetic disease. In these patients, respiratory infections contribute[…]
Monitoring the integrity of DNA is the function of the many repair systems present in[…]
The bacterium Mycobacterium tuberculosis, the agent of human tuberculosis, has developed different strategies to attenuate[…]
Although antiretroviral therapies are effective in reducing viral load in HIV-1 infected patients, one of[…]
Inflammatory bowel disease (IBD) and asthma are chronic inflammatory disorders of the gut and airways,[…]
In the context of the emergence of new variants of SARS-CoV-2, increasingly resistant to vaccines[…]
Scientists have discovered a novel mechanism of resistance to metal intoxication in macrophages involving mobile[…]
Despite its importance as a therapeutic target against tuberculosis, the structure of Pks13 (PolyKetide Synthase[…]
Immunotherapy, a therapeutic strategy aimed at increasing the activity of the immune system in order[…]
In this study published in the journal “Cell Death and Disease”, IPBS scientists highlight a[…]